State-of-the-Art Review on Diabetes Care in Italy.
Diabetes is a significant health problem in Italy as in other western countries.



To review available epidemiological data and the legislative framework for diabetes care in Italy.



Review of Italian Health Ministry's official documents and analysis of epidemiological data published by Italian Scientific Societies.



Diabetes affects more than 5% of the Italian population. The expenditures for the care of people with diabetes are about €10 billion ($US 11 billion) a year and are increasing over time. Italian law regulates the clinical care of people with diabetes and creates a clinical framework involving medical organizations, prevention programs, personnel training, and legal protection. The National Health Program is structured in essential levels of assistance that can be defined differently in the various regions. In 2013, the "National Diabetes Plan," defining priority areas for intervention, was approved and represents the main regulatory tool for the management of diabetes within the Italian National Health Service. In Italy, the status of diabetes care is being monitored using the data from 2 permanent observatories: the ARNO Observatory Diabetes and the Associazione Medici Diabetologi Annals.



A comprehensive approach to diabetes is offered to all citizens, consonant with the constitutionally guaranteed right to health. However, this important effort translates into a relevant financial burden for the National Health Service.
Diabetology Department, Niguarda Hospital, Milan, Italy.
Olga
O
Disoteo
Division of Endocrinology, Metabolic Diseases and Clinical Nutrition, University Hospital Santa Maria della Misericordia, Udine, Italy. Electronic address: grimaldi.franco@aoud.sanita.fvg.it.
Franco
F
Grimaldi
Department of Endocrinology and Metabolism, Regina Apostolorum Hospital, Albano Laziale (Rome), Italy.
Enrico
E
Papini
Endocrinology Service, Galeazzi Institute IRCCS, Milan, Italy.
Roberto
R
Attanasio
Division of Endocrinology, Metabolic Diseases and Clinical Nutrition, University Hospital Santa Maria della Misericordia, Udine, Italy.
Laura
L
Tonutti
Division of Endocrinology, Metabolic Diseases and Clinical Nutrition, University Hospital Santa Maria della Misericordia, Udine, Italy.
Maria Antonietta
MA
Pellegrini
Department of Endocrinology and Metabolism, Regina Apostolorum Hospital, Albano Laziale (Rome), Italy.
Rinaldo
R
Guglielmi
Division of Endocrinology and Metabolism, Santa Croce and Carle Hospital, Cuneo, Italy.
Giorgio
G
Borretta
D003362:Cost-Benefit Analysis; D003920:Diabetes Mellitus / Q000191:economics* / Q000453:epidemiology / Q000628:therapy*; D005102:Health Expenditures / Q000706:statistics & numerical data*; D006295:Health Resources; D006801:Humans; D007558:Italy; D009313:National Health Programs / Q000191:economics*; D015995:Prevalence; D019984:Quality Indicators, Health Care; D016896:Treatment Outcome
Italy; costs; diabetes; diabetes care; diabetic complications; legislative framework; prevalence